ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 31921634

Role of Matrix Metalloproteinases in Angiogenesis and Cancer.

Quintero-Fabián S and 7 others. Front Oncol, 2019. Cited by 784 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Role of Matrix Metalloproteinases in Angiogenesis and Cancer. Papers, record 31921634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31921634

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of Matrix Metalloproteinases in Angiogenesis and Cancer.
PubMed
Journal
Front Oncol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
784
iCite
Relative citation ratio, by iCite
37.7
iCite
Revised in PubMed
2020-10-01
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Quintero-Fabián SSaray
2Arreola RRodrigo
3Becerril-Villanueva EEnrique
4Torres-Romero JCJulio César
5Arana-Argáez VVictor
6Lara-Riegos JJulio
7Ramírez-Camacho MAMario Alberto
8Alvarez-Sánchez MEMaría Elizbeth

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References201

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124,292,449Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.Br J Cancer2014https://conductscience.org/library/papers/24292449PubMed
213,130,303Targeting HIF-1 for cancer therapy.Nat Rev Cancer2003https://conductscience.org/library/papers/13130303PubMed
319,011,622Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat Cell Biol2008https://conductscience.org/library/papers/19011622PubMed
422,460,086VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue.Med Sci Monit2012https://conductscience.org/library/papers/22460086PubMed
520,627,072Tumors as organs: complex tissues that interface with the entire organism.Dev Cell2010https://conductscience.org/library/papers/20627072PubMed
622,262,494The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects.Int J Cancer2012https://conductscience.org/library/papers/22262494PubMed
725,846,944Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.Int J Mol Med2015https://conductscience.org/library/papers/25846944PubMed
825,918,379IL-33 activates tumor stroma to promote intestinal polyposis.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/25918379PubMed
916,510,584Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.Cancer Res2006https://conductscience.org/library/papers/16510584PubMed
1017,322,177Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice.Circ Res2007https://conductscience.org/library/papers/17322177PubMed

1 to 10 of 201

See all 201 references

Cited by580

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 784 citations.

PMIDTitleJournalYearIn PapersSource
42,974,381Astrocyte plasticity shapes brain metastasis progression through tumor-astrocyte crosstalk.Cancer Heterog Plast2025https://conductscience.org/library/papers/42974381PubMed
42,927,554Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study.Mol Biol Rep2026https://conductscience.org/library/papers/42927554PubMed
42,908,026Capsaicin enhances chemosensitivity and mitigates MMP11-driven aggressiveness in human bladder cancer.Cancer Cell Int2026https://conductscience.org/library/papers/42908026PubMed
42,889,244Targeting vascular endothelial growth factor (VEGF)-induced angiogenesis with Rosa hybrida leaf extract via VEGF receptor-2 signaling and matrix metalloproteinase-2 inhibition.Nutr Res Pract2026https://conductscience.org/library/papers/42889244PubMed
42,875,645A review on MMP-2 modulating agents from natural and synthetic sources and their role in inflammatory bowel disease.Inflammopharmacology2026https://conductscience.org/library/papers/42875645PubMed
42,795,816Optimizing the Endometrial Factor in Recurrent Implantation Failure: From Established Diagnostics to Mechanism-Informed Management.J Clin Med2026https://conductscience.org/library/papers/42795816PubMed
42,792,211Probiotics and Extracellular Vesicles as Redox Modulators in Wound Healing: From Microbial Therapeutics to Engineered Nanotherapeutic Strategies.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792211PubMed
42,693,402Hepatic Granulomatous Inflammation and Angiogenesis Upregulation Provoked by Acanthamoeba polyphaga Infection and Role of Quercetin-Conjugated Silver Nanoparticles.Parasite Immunol2026https://conductscience.org/library/papers/42693402PubMed
42,622,702High-sucrose diet induces MMP-9 activation and collagen deposition via oxidative stress in Swiss mice liver.Histochem Cell Biol2026https://conductscience.org/library/papers/42622702PubMed
42,621,297Carbon Ion Irradiation Suppresses Tumor Growth, Migration and Invasion in X-ray Resistant Melanoma in Vitro and in Vivo.Dose Response2026https://conductscience.org/library/papers/42621297PubMed

1 to 10 of 580

See all 580 cited by

Genes161

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACAN176PubTator's text mininghttps://conductscience.org/library/genes/176NCBI Gene
ADAM10102PubTator's text mininghttps://conductscience.org/library/genes/102NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ANG283PubTator's text mininghttps://conductscience.org/library/genes/283NCBI Gene
ANGPT1284PubTator's text mininghttps://conductscience.org/library/genes/284NCBI Gene
ANGPT2285PubTator's text mininghttps://conductscience.org/library/genes/285NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ARHGEF57,984PubTator's text mininghttps://conductscience.org/library/genes/7984NCBI Gene
AZGP1563PubTator's text mininghttps://conductscience.org/library/genes/563NCBI Gene
BNIP3664PubTator's text mininghttps://conductscience.org/library/genes/664NCBI Gene

1 to 10 of 161

See all 161 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31921634

GET https://conductscience.org/api/papers/v1/31921634/references?page=2

API referenceFor AI assistants